BlackRock, Inc.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 2012383 New York, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,164,738,910

+$202,828,622 QoQ

Shares Held

63,894,301

-1.9% QoQ

Ownership

5.48%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

of 675 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,294,529	$2,868,734,637
2	ZTS	Zoetis Inc.	39,430,181	$2,833,452,797
3	NBIX	Neurocrine Biosciences Inc	13,711,607	$2,310,954,234
4	TEVA	Teva Pharmaceutical Industries Ltd This page	63,894,301	$2,164,738,910
5	ALKS	Alkermes plc.	29,235,739	$1,531,952,715
6	VTRS	Viatris Inc	86,019,468	$1,365,989,144
7	ELAN	Elanco Animal Health Inc	48,849,973	$1,202,197,829
8	HIMS	Hims & Hers Health, Inc.	28,703,514	$995,150,823

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,164,738,910	63,894,301	-1.9%	Shares	Sole	2026-08-07
2026-03-31	$1,961,910,288	65,136,464	+11.7%	Shares	Sole	2026-05-13
2025-12-31	$1,819,626,884	58,302,688	+0.9%	Shares	Sole	2026-02-12
2025-09-30	$1,167,608,633	57,802,408	+6.4%	Shares	Sole	2025-11-12
2025-06-30	$910,376,073	54,318,382	+4.0%	Shares	Sole	2025-08-12
2025-03-31	$802,681,225	52,223,893	+3.2%	Shares	Sole	2025-05-02
2024-12-31	$1,114,867,517	50,583,826	+15.5%	Shares	Sole	2025-02-07
2024-09-30	$789,278,926	43,800,163	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.